Private equity firm CapVest will continue to be the majority shareholder of Curium Pharma, the world’s largest pure play nuclear medicine producer, for another three-to-five-year investment round. The company is being moved to a continuation vehicle in a recapitalisation deal that values it at around $7 billion.
Archives
Mehilainen offers three-year price freeze in Romanian fertility to allay competition concern over Regina Maria acquisition
Romania’s Competition Council has raised concerns about multinational Finnish outpatient group Mehilainen’s acquisition of Romania’s largest private healthcare group, Regina Maria.
November 27, 2025
FREE BLOG Thoughts on digital health
Last week we published a Special Report on digital health. This is the first time we’ve published an in-depth report on this topic, but most likely won’t be the last. The report looks at the major avenues and frontiers of innovation in healthcare’s digital revolution, and includes case study interviews of eight different digital health […]
November 27, 2025
HBI’s Digital Health Special Report 2025
HBI's first ever Special Report on digital health features analysis and commentary from various experts on the current state of play in digital health, and where the market might be headed, as well as in depth case study interviews with eight different digital health companies, each showcasing a different aspect to healthcare's digital revolution: HealthHero, Kry/Livi, Arts en Zorg, Health Navigator (HN), Helfie AI, Clue, Hellobetter and Flow Neuroscience.
November 20, 2025
Circio looking for partners to help bring circular RNA gene therapy technology to market
Circio, a pre-clinical biotech company that is listed on the Oslo stock exchange, has developed a form of RNA technology that, if successful, could make cell and gene therapy much safer, more effective and more economic, and therefore available to a wide population. HBI sat down with Lubor Gaal, the company’s CFO, at Jefferies’ Global Healthcare Conference in London this week, to understand a bit more about the technology and what the company needs to get to market.
November 20, 2025
Kooth continues US expansion with Kismet acquisition
UK-based listed digital mental healthcare group Kooth is continuing its expansion into the US market with the acquisition of Kismet, a small US digital mental healthcare company that specialises in under 12s. Kooth’s CEO Kate Newhouse tells us the acquisition will expand the capabilities and reach of Kooth’s US platform Soluna.
November 20, 2025
EDG buys Dutch dentistry group Fresh Tandartsen from Livingbridge
European Dental Group (EDG), Europe’s second largest dental group by revenue, has bought Fresh Tandartsen, a 41-clinic competitor in its home market of the Netherlands.
November 20, 2025
New Zealand-based Vital buys back management rights from Northwest Healthcare REIT
Vital Healthcare Property Trust, a listed New Zealand-based healthcare real estate investor, has bought back (internalised) its management rights from Canada-based Northwest Healthcare REIT (one of the world’s largest hospital-focused REITs), generating NZ$214 Million (~$170 million USD) for Northwest.
November 13, 2025
HBI Exclusive: Welltower buys propco and opco of Aria Care and Danforth Care
US healthcare REIT Welltower has acquired two medium-sized UK care home groups as part of its several-billion-pound investment into the UK’s care sector: it has acquired both the opco and the propco of Aria Care and Danforth Care.
November 13, 2025
News in brief: Doctolib fined €4.7m by French competition authority
France’s competition authority (Autorité de la concurrence) has issued a €4.7 million fine to telehealth platform Doctolib for using exclusivity clauses and for ‘predatory acquisition’ of a rival platform, MonDocteur, in 2018.
November 6, 2025
Fremman buys Stingray to merge with Amethyst
Two of Europe’s three largest private oncology groups are being merged into a single entity, creating continental Europe’s largest oncology player. Private equity firm Fremman Capital has acquired Stingray, an oncology group with a presence in France and Germany, to merge it with its portfolio company Amethyst, a major pan-European radiotherapy group which already has a presence in seven European countries.
November 6, 2025
Australia’s largest health insurer Medibank buys primary care chain Better Medical
Medibank, the largest private health insurer in Australia, is buying Better Medical, a 61-clinic primary care chain, from private equity firm Livingbridge, for A$159 million (~$103 million). This is part of a wider trend of vertical consolidation by insurers within Australia’s private healthcare market, which is raising concerns amongst many in the sector that it could lead to harmful cost cutting.
